Navigating Growing Pains for Life Science Companies Experiencing Rapid Growth
10:30 AM – 11:30 AM |
Fast-growing pharmaceutical companies face a delicate balance between planning for expansion, uncertain capital availability and compliance risks. The purpose of this discussion is to review these challenges from the perspective of real estate needs, timing, implementing security, inventory protocols, new SOPs, and cGXP standards — all while addressing increasing performance/production demands. Pat Gallagher will moderate the discussion with a panel of executives in the pharmaceutical industry who have navigated these challenges. The panel will draw on their experiences and lessons learned. Main takeaways will include:
– Navigating compliance issues: the risks and planning for them
– Often overlooked Operational facets of growing pains and the impact they can have to daily operations
– Negotiating uncertainties in real estate needs and capital
Pat Gallagher | President & CEO | Hereva Consultants
Patrick Gallagher (Pat) is President & CEO of Hereva Consultants, a real estate consultancy dedicated to understanding Clients’ needs and guiding their vision to reality. He has over 25 years of experience in the construction industry, with a primary focus on Owners’ Project Representation in research and technology sectors. Pat’s main forte and passion is in helping pharmaceutical clients with real estate and operational needs, particularly as their companies grow. His clients include Moderna, Foundation Medicine, Alnylam and Thermo Fisher scientific, to name a few.
Pat began his career as a QS (quantity surveyor – cost/contract consulting) in London; where he was responsible for managing the commercial aspects of project delivery, including procurement, contracts, and cost management to project close-out. Working on diverse projects, he developed a wide range of lifecycle costing and project delivery skills. Prior to forming Hereva, Pat was Director of Operations of the Boston office for an international project management consulting firm. As such, he was responsible for all business operations, client relations and staff development.
Charles Pappalardo | VP, Global Operations & Real Estate | Vertex Pharmaceuticals
Chuck maintains over 25 years of experience within the science and technology sector being immediately involved in global real estate, large scale capital projects, facilities engineering and management, global environment, health and safety, corporate security and related technical and operational support functions. He possesses extensive knowledge in developing science and technology facilities from the ground up having been involved in all stages of the process: developing and managing successful project teams in the planning, construction, delivery and validation of multiple large scale facilities worldwide. Chuck’s current responsibilities at Vertex include oversight over the company’s facility global assets including Planning, Construction, Operations, Security, EHS, Business Continuity and Real Estate. Chuck is a member in the International Society of Pharmaceutical Engineers (ISPE), International Facilities Managers Association (IFMA) and CORNET.
Chuck is a graduate of both Norwich University and Umass Lowell obtaining both undergraduate and graduate degrees in Engineering Technology and Environmental Science. Chairman, Seaport Transportation Management Association
Ed Dondero | Director of Real Estate & Planning | Biogen
Ed has had over thirty years of experience in the biomedical field while also working for Tufts University and Shire Pharmaceuticals. His responsibilities have included the management of small and large lab, office and manufacturing projects, energy management and the supervision of an operation and maintenance staff. Presently his duties are the oversight and administration of global real estate and master space planning functions.
Education: BS in Construction Management from Wentworth Institute of Technology and an MBA from Bentley College